Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Choi

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Case Reports in Oncology|February 26, 2024
Acquired Angioedema Associated with Lymphoproliferative DisordersJun Yen Ng, Meidelynn Ooi, Samuel K Bennett, et al.
Frontiers in Neurology|December 28, 2020
Reduced Impact of Endovascular Thrombectomy on Disability in Real-World Practice, Relative to Randomized Controlled Trial Evidence in AustraliaLan Gao, Elise Tan, Marj Moodie, et al.
Journal of Neurointerventional Surgery|March 21, 2023
Prior anticoagulation and bridging thrombolysis improve outcomes in patients with atrial fibrillation undergoing endovascular thrombectomy for anterior circulation strokeLongting Lin, Christopher Blair, James Fu, et al.
Frontiers in Neurology|December 31, 2021
Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic StrokeLan Gao, Andrew Bivard, Mark Parsons, et al.
Frontiers in Neurology|February 15, 2021
What Is the "Optimal" Target Mismatch Criteria for Acute Ischemic Stroke?Chushuang Chen, Mark W Parsons, Christopher R Levi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 19, 2023
Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocolAndrew Bivard, Carlos Garcia-Esperon, Leonid Churilov, et al.
Leukemia & Lymphoma|November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomasDaniel Fasser, Greta Joy, Mark R Dowling, et al.
Vaccine|March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in AustraliaLucy Deng, Belinda Barton, Philip Choi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Case Reports in Oncology|February 26, 2024
Acquired Angioedema Associated with Lymphoproliferative DisordersJun Yen Ng, Meidelynn Ooi, Samuel K Bennett, et al.
Frontiers in Neurology|December 28, 2020
Reduced Impact of Endovascular Thrombectomy on Disability in Real-World Practice, Relative to Randomized Controlled Trial Evidence in AustraliaLan Gao, Elise Tan, Marj Moodie, et al.
Journal of Neurointerventional Surgery|March 21, 2023
Prior anticoagulation and bridging thrombolysis improve outcomes in patients with atrial fibrillation undergoing endovascular thrombectomy for anterior circulation strokeLongting Lin, Christopher Blair, James Fu, et al.
Frontiers in Neurology|December 31, 2021
Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic StrokeLan Gao, Andrew Bivard, Mark Parsons, et al.
Frontiers in Neurology|February 15, 2021
What Is the "Optimal" Target Mismatch Criteria for Acute Ischemic Stroke?Chushuang Chen, Mark W Parsons, Christopher R Levi, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|January 19, 2023
Tenecteplase versus alteplase for stroke thrombolysis evaluation (TASTE): A multicentre, prospective, randomized, open-label, blinded-endpoint, controlled phase III non-inferiority trial protocolAndrew Bivard, Carlos Garcia-Esperon, Leonid Churilov, et al.
Leukemia & Lymphoma|November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomasDaniel Fasser, Greta Joy, Mark R Dowling, et al.
Vaccine|March 24, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in AustraliaLucy Deng, Belinda Barton, Philip Choi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 22, 2024
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss I Baker, Philip Choi, Nicola Curry, et al.
BMJ Open|April 29, 2022
Tenecteplase versus Alteplase for Stroke Thrombolysis Evaluation Trial in the Ambulance (Mobile Stroke Unit-TASTE-A): protocol for a prospective randomised, open-label, blinded endpoint, phase II superiority trial of tenecteplase versus alteplase for ischaemic stroke patients presenting within 4.5 hours of symptom onset to the mobile stroke unitAndrew Bivard, Henry Zhao, Skye Coote, et al.
Pageof 4